Recent studies indicate that some individuals can maintain weight loss after halting GLP-1 treatment, challenging previous findings from clinical trials. Initially, research showed that patients often regained most of the weight once they stopped using GLP-1 therapies.
One such example is Brandon Chargoy, a 31-year-old who faced ongoing issues with weight management. Despite trying various diets and fitness trends, sustained success eluded him. After receiving a Type 2 diabetes diagnosis, his healthcare provider prescribed semaglutide, a GLP-1 receptor agonist.